Sio Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001482416

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2026 · 54 positions · Total reported value $506.72M · Top-10 concentration 47.9% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 61.6% · 14 new · 12 cut · 19 exited

Active Share (vs S&P 500): 99.1% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -6.4% · vs SPY -8.6% · Prev Value $604.29M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.5% · vs SPY -3.6% · Latest Value $506.72M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Sio Capital Management, LLC disclosed 54 equity positions with a combined reported value of $506.72M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 47.9% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were AVR ($40.24M), GMED ($35.66M), GSK ($32.33M). By sector, the heaviest allocations are Health Care 95.9%, Consumer Discretionary 2.8%. Versus the prior quarter, allocation shifted toward Health Care (+9.3pp), Financials (+1.0pp) and away from Industrials (-1.2pp), Other (-2.4pp).

Versus the prior quarter, Sio Capital Management, LLC opened 14 new positions, trimmed 12 and fully exited 19, a turnover rate of 61.6% of positions. The portfolio's overlap with the prior quarter was 55% of names.

The largest new positions opened in Q3 2026 were MRK ($21.14M), PFE ($17.11M), REPL ($11.46M).

Of the 19 positions fully exited versus the prior quarter, the largest were COR ($49.12M), TYRA ($22.21M), WAY ($19.01M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • MRK MERCK & CO INC · $21.14M
  • PFE PFIZER INC · $17.11M
  • REPL REPLIMUNE GROUP INC · $11.46M
  • BMRN BIOMARIN PHARMACEUTICAL INC · $10.46M
  • AZN ASTRAZENECA PLC · $9.99M
  • COO COOPER COS INC · $8.93M
  • LQDA LIQUIDIA CORPORATION · $8.53M
  • PTCT PTC THERAPEUTICS INC · $5.37M

Fully Exited (vs previous quarter)

  • COR CENCORA INC · prev qtr: $49.12M
  • TYRA TYRA BIOSCIENCES INC · prev qtr: $22.21M
  • WAY WAYSTAR HLDG CORP · prev qtr: $19.01M
  • ORKA ORUKA THERAPEUTICS INC · prev qtr: $16.86M
  • CCRN CROSS CTRY HEALTHCARE INC · prev qtr: $14.51M
  • ABT ABBOTT LABORATORIES · prev qtr: $11.67M
  • ZBH ZIMMER BIOMET HOLDINGS INC · prev qtr: $11.32M
  • REGN REGENERON PHARMACEUTICALS · prev qtr: $11.22M

Insider Transactions (Form 4)

Latest Sio Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sio Capital Management, LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 59 positions worth $604.29M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-78021 (status: Approved), registered 2013-05-16
  • Regulatory AUM (Form ADV): $1.29B as of 2026-03-18
  • Client mix (by RAUM): pension and profit-sharing plans 53%, pooled investment vehicles 47%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: siocapital.com

Portfolio Structure

  • 59 positions · $604.29M reported value (Q2 2026)
  • Top 10 holdings = 48.6% of reported value
  • Largest position: AVR (ANTERIS TECHNOLOGIES GLOBAL COM) at 9.0%
  • Average position size: $10.24M

Sector Tilt

  • Health Care 86.6%
  • Consumer Discretionary 6.4%
  • Information Technology 3.1%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q2 2026: 16 new, 10 added, 22 reduced, 33 exited
  • 11 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund is aggressively increasing exposure to Health Care (100% of top-10 holdings), with a bullish tilt toward biotech/therapeutics (e.g., GMED, GSK, ICLR) and new positions in large caps (MRK, PFE), suggesting a tactical bet on sector momentum and pipeline catalysts. 2. Key moves: - Added: GMED (+57.7% shares), GSK (+53.7%), ICLR (+59.9%), SENS (+43.8%), IDYA (+4.1%). - Reduced: AVR (-6.6% shares), SNY (-2.2%). - New: MRK, PFE. - Hold: SLS. 3. Portfolio structure: Highly active, concentrated (54 positions), and sector-concentrated (Health Care dominant), indicating high conviction and appetite for biotech volatility. 4. Per-holding one-liner: - AVR: ANTERIS TECHNOLOGIES GLOBAL (unverified, likely regenerative medicine). - GMED: GLOBUS MED INC (unverified, likely surgical devices). - GSK: GSK PLC (pharmaceuticals/vaccines). - ICLR: ICON PUB LTD CO (clinical research). - SENS: SENSEONICS HLDGS INC (continuous glucose monitoring). - MRK: MERCK & CO INC (oncology/immunology). - IDYA: IDEAYA BIOSCIENCES INC (oncology targeted therapies). - PFE: PFIZER INC (vaccines/COVID-19). - SLS: SELLAS LIFE SCIENCES GROUP I (unverified, likely oncology). - SNY: SANOFI SA (vaccines/diabetes). 5. Style summary: Aggressive Health Care tilt with concentrated biotech bets and new large-cap pharma additions, signaling high conviction in sector innovation.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 05:09

Sector Allocation

Health Care 95.9%
Financials 1.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 5.18M $40.24M 7.94%
7.94%
Reduce
2 476.11K $35.66M 7.04%
7.04%
Add
3 671.12K $32.33M 6.38%
6.38%
Add
4 141.00K $23.97M 4.73%
4.73%
Add
5 2.29M $23.30M 4.60%
4.60%
Add
6 145.49K $21.14M 4.17%
4.17%
New
7 500.12K $19.21M 3.79%
3.79%
Add
8 600.00K $17.11M 3.38%
3.38%
New
9 1.23M $15.15M 2.99%
2.99%
Hold
10 356.18K $14.69M 2.90%
2.90%
Reduce
11 9.10M $14.57M 2.88%
2.88%
Reduce
12 268.28K $14.27M 2.82%
2.82%
Reduce
13 3.63M $13.68M 2.70%
2.70%
Add
14 755.49K $13.39M 2.64%
2.64%
Reduce
15 1.01M $12.56M 2.48%
2.48%
Add
16 865.33K $11.46M 2.26%
2.26%
New
17 428.86K $10.70M 2.11%
2.11%
Add
18 146.27K $10.63M 2.10%
2.10%
Add
19 174.31K $10.46M 2.06%
2.06%
New
20 126.34K $10.05M 1.98%
1.98%
Add
21 61.85K $9.99M 1.97%
1.97%
New
22 291.23K $9.79M 1.93%
1.93%
Reduce
23 873.38K $9.76M 1.93%
1.93%
Reduce
24 33.94K $9.22M 1.82%
1.82%
Reduce
25 158.05K $8.93M 1.76%
1.76%
New
26 282.00K $8.53M 1.68%
1.68%
New
27 561.29K $6.90M 1.36%
1.36%
Reduce
28 1.99M $6.07M 1.20%
1.20%
Add
29 3.63M $6.07M 1.20%
1.20%
Add
30 1.28M $5.92M 1.17%
1.17%
Reduce
31 82.90K $5.37M 1.06%
1.06%
New
32 766.36K $5.23M 1.03%
1.03%
New
33 500.00K $5.10M 1.01%
1.01%
New
34 44.70K $4.71M 0.93%
0.93%
New
35 529.15K $4.38M 0.86%
0.86%
New
36 2.00M $4.00M 0.79%
0.79%
Add
37 75.15K $3.74M 0.74%
0.74%
Add
38 657.10K $3.39M 0.67%
0.67%
Add
39 1.08M $2.95M 0.58%
0.58%
Hold
40 548.10K $2.92M 0.57%
0.57%
Add
41 132.10K $2.84M 0.56%
0.56%
Add
42 95.46K $2.57M 0.51%
0.51%
Reduce
43 1.01M $2.50M 0.49%
0.49%
Hold
44 327.24K $1.84M 0.36%
0.36%
Hold
45 481.60K $1.78M 0.35%
0.35%
New
46 184.42K $1.50M 0.30%
0.30%
New
47 152.46K $1.38M 0.27%
0.27%
Hold
48 373.67K $1.22M 0.24%
0.24%
Reduce
49 440.45K $1.12M 0.22%
0.22%
Add
50 904.27K $1.07M 0.21%
0.21%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 50% R 50% F1 50% (modelled on 2026-Q2; 5/10 hit)

Low-confidence forecast This fund replaces about 53% of its Top-10 each quarter and backtests at F1 46% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 46% · recall 46% · F1 46% · avg rank error 4.0 · Top-10 turnover 53%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 50% 50% 50% MRTX · GRCL · CI · LH · GMED · INSM · GSK · IMGN · UTHR · EMBC LH · INSM · CI · GMED · MDGL · GSK · ZBH · MDT · OGN · TYRA
2024-Q2 50% 50% 50% LH · INSM · CI · GMED · MDGL · GSK · ZBH · MDT · TYRA · OGN INSM · LH · TFX · ZBH · SNN · PCRX · OGN · GSK · CRBP · VXRT
2024-Q3 40% 40% 40% INSM · LH · TFX · ZBH · PCRX · SNN · OGN · GSK · CRBP · TYRA LH · ISRG · TEVA · MMS · ZBH · VXRT · KVUE · TFX · TYRA · IRON
2024-Q4 40% 40% 40% LH · ISRG · TEVA · ZBH · MMS · VXRT · TFX · KVUE · TYRA · IRON ICLR · MMS · CI · LH · SNY · ZBH · DRUG · AVR · ANNX · TFX
2025-Q1 60% 60% 60% ICLR · MMS · CI · LH · ZBH · SNY · DRUG · ANNX · AVR · TFX ICLR · MMS · MRK · ZBH · NBIX · LH · DRUG · GMED · TFX · EMBC
2025-Q2 50% 50% 50% MMS · ICLR · MRK · ZBH · NBIX · DRUG · LH · TFX · EMBC · GMED MMS · IRON · GMED · CNC · MRK · DRUG · NBIX · BMRN · ANNX · IDXX
2025-Q3 40% 40% 40% MMS · IRON · CNC · GMED · BMRN · DRUG · MRK · NBIX · ANNX · IDXX MMS · CELC · SNY · DNTH · ALKS · IRON · MRK · HSIC · CNC · KVUE
2025-Q4 40% 40% 40% MMS · CELC · SNY · DNTH · IRON · ALKS · CNC · KVUE · HSIC · MRK CELC · CI · SNY · MMS · ZBH · RYTM · KVUE · OGN · ICLR · WAY
2026-Q1 40% 40% 40% CI · SNY · CELC · MMS · ZBH · KVUE · RYTM · OGN · ICLR · DNTH MMS · WAY · ICLR · COR · DNTH · AVR · CORT · LIVN · TYRA · CELC
2026-Q2 50% 50% 50% MMS · WAY · ICLR · COR · AVR · DNTH · LIVN · CORT · TYRA · ANIP AVR · COR · MMS · ALLO · GMED · GSK · TYRA · WAY · SLS · IDYA
2026-Q3 ★ 50% 50% 50% AVR · COR · MMS · ALLO · GMED · GSK · TYRA · WAY · IDYA · SLS AVR · GMED · GSK · ICLR · SENS · MRK · IDYA · PFE · SLS · SNY

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings6 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return+14.36%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+31.37%vs benchmark
Barra annualised vol34.1%Model estimate
Realised vol30.7%Annualised in window
Weighted beta0.73Raw exposure
Factor / specific risk41% / 59%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)77.388.098.7109.3120.010-0110-2311-16Sio Capital Management, LLCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+14.36%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return+31.37%Portfolio − benchmark
Arithmetic return sum+14.04%Difference vs compounded is the cross term
Weighted raw beta0.73Weighted holding betas
Realised volatility (annualised)30.70%Daily returns in window
Barra model volatility (annualised)34.10%Factor + specific
Factor share of variance41.1%Barra factors
Specific share of variance58.9%Stock residuals
Reported value$83.6M13F long US equity

2. Return attribution

The +14.04% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +0.73% 5.2%
Momentum & Growth 3 -4.25% -30.2%
Volatility & Tail Risk 7 +4.06% 28.9%
Industry 12 +6.98% 49.8%
Specific 1 +6.50% 46.3%
Return attribution (style + industry, %)-7.5-3.8+0.0+3.8+7.5Growth-0.39Amihud Illiquidity-0.49Beta-0.59Max Drawdown+0.73Turnover+0.84Non-linear Size+0.86Skewness-1.12Size+1.29Mid Cap-1.71Momentum-3.75Residual Volatility+4.20Historical Volatility-4.46Kurtosis+5.52Health Care+6.98
Factor Type Exposure Factor return Contribution Share of |return|
Health Care Industry +1.00 +6.98% +6.98% 49.8%
Specific Specific — — +6.50% 46.3%
Kurtosis Style +0.73 +7.51% +5.52% 39.3%
Residual Volatility Style +1.27 +3.29% +4.20% 29.9%
Size Style -0.66 -1.95% +1.29% 9.2%
Non-linear Size Style +0.86 +1.01% +0.86% 6.2%
Turnover Style -0.17 -4.80% +0.84% 6.0%
Max Drawdown Style -0.42 -1.76% +0.73% 5.2%
Liquidity Style -0.17 +0.36% -0.06% -0.4%
Short-term Reversal Style -0.13 +0.87% -0.11% -0.8%
Leverage (Downside Vol) Style +0.13 -1.71% -0.22% -1.5%
Growth Style -0.22 +1.75% -0.39% -2.7%
Amihud Illiquidity Style +1.11 -0.45% -0.49% -3.5%
Beta Style -0.13 +4.44% -0.59% -4.2%
Skewness Style +0.25 -4.39% -1.12% -8.0%
Mid Cap Style +0.88 -1.94% -1.71% -12.2%
Momentum Style +0.94 -4.00% -3.75% -26.7%
Historical Volatility Style +0.32 -14.00% -4.46% -31.8%

3. Risk attribution

Annualised volatility is 34.10%; factor risk explains 41.1% of variance and specific risk 58.9%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-63.7-31.8+0.0+31.8+63.7Residual Volatility-1.79Skewness+0.35Non-linear Size+0.37Short-term Reversal+0.40Growth+0.69Kurtosis+0.84Historical Volatility+0.87Amihud Illiquidity+1.78Mid Cap+2.59Max Drawdown+2.65Size+2.97Momentum+6.39Health Care+22.73Specific+58.94
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 58.9% +20.10% 20.1%
Health Care Industry +1.00 22.7% +7.75% 7.8%
Momentum Style +0.94 6.4% +2.18% 2.2%
Size Style -0.66 3.0% +1.01% 1.0%
Max Drawdown Style -0.42 2.6% +0.91% 0.9%
Mid Cap Style +0.88 2.6% +0.88% 0.9%
Amihud Illiquidity Style +1.11 1.8% +0.61% 0.6%
Historical Volatility Style +0.32 0.9% +0.30% 0.3%
Kurtosis Style +0.73 0.8% +0.29% 0.3%
Growth Style -0.22 0.7% +0.24% 0.2%
Short-term Reversal Style -0.13 0.4% +0.14% 0.1%
Non-linear Size Style +0.86 0.4% +0.13% 0.1%
Skewness Style +0.25 0.3% +0.12% 0.1%
Liquidity Style -0.17 0.3% +0.11% 0.1%
Residual Volatility Style +1.27 -1.8% -0.61% -0.6%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-0.9-0.10.71.52.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.66 +2.10 -2.76
Non-linear Size +0.86 +1.68 -0.82
Mid Cap +0.88 +0.13 +0.76
Beta -0.13 +1.29 -1.43
Momentum +0.94 +0.72 +0.22
Short-term Reversal -0.13 -0.64 +0.51
Residual Volatility +1.27 -0.40 +1.68
Historical Volatility +0.32 +0.86 -0.54
Liquidity -0.17 +0.11 -0.29
Amihud Illiquidity +1.11 +1.16 -0.05
Turnover -0.17 +0.21 -0.38
Growth -0.22 +0.58 -0.80
Leverage (Downside Vol) +0.12 +0.14 -0.02
Skewness +0.25 +0.24 +0.02
Kurtosis +0.73 +0.21 +0.52
Max Drawdown -0.42 -0.08 -0.33

5. Industry allocation & Brinson

Industry allocation (weight, %)-10.020.050.080.0110.0Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -22.33% +3.83% +16.44% -16.44% +16.44%
Health Care 100.0% 1.7% +14.70% +8.29% +24.98% +0.11% +6.30% +14.55%
Communication Services 0.0% 2.6% +0.00% -17.64% +0.01% +0.46% -0.46% +0.46%
Utilities 0.0% 0.8% +0.00% +11.13% -0.22% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.26% -0.27% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +3.76% -1.84% -0.33% +0.33% -0.33%
Industrials 0.0% 11.1% +0.00% +4.36% -2.39% -0.48% +0.48% -0.48%
Total +23.98% +15.95% -9.54% +30.39%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
ICLR ICON PUB LTD CO Health Care 28.69% +12.60% +3.61% Add
MRK MERCK & CO INC Health Care 25.30% -0.58% -0.15% New
TNGX TANGO THERAPEUTICS INC Health Care 12.81% -3.13% -0.40% Add
AZN ASTRAZENECA PLC Health Care 11.95% +13.96% +1.67% New
CI THE CIGNA GROUP Health Care 11.04% +10.42% +1.15% Reduce
LQDA LIQUIDIA CORPORATION Health Care 10.21% +86.29% +8.81% New
Contribution rank Symbol Sector Weight Return Contribution
1 LQDA Health Care 10.21% +86.29% +8.81%
2 ICLR Health Care 28.69% +12.60% +3.61%
3 AZN Health Care 11.95% +13.96% +1.67%
4 CI Health Care 11.04% +10.42% +1.15%
5 MRK Health Care 25.30% -0.58% -0.15%
6 TNGX Health Care 12.81% -3.13% -0.40%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned +14.36%, versus -17.01% for the QQQ synthetic benchmark — an excess of +31.37%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +6.98%, Kurtosis +5.52%, Residual Volatility +4.20%; the largest drags came from Historical Volatility -4.46%, Momentum -3.75%, Mid Cap -1.71%. Specific (stock-level) return contributed +6.50%.
  3. Risk attribution: Barra model volatility is 34.10% annualised; factor risk explains 41% of variance and specific risk 59%. The largest factor risk sources are Health Care 22.7%, Momentum 6.4%, Size 3.0%.
  4. Style tilt: size -0.66, momentum +0.94, volatility +0.32, liquidity -0.17; the weighted raw beta is 0.73. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+98.3 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +23.98%, selection +15.95% and interaction -9.54%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Sio Capital Management, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Sio Capital Management, LLC reported 54 equity positions worth $506.72M in aggregate; its largest disclosed positions were AVR ($40.24M), GMED ($35.66M), GSK ($32.33M).

How large is Sio Capital Management, LLC's portfolio?

Sio Capital Management, LLC reported $506.72M of long equity holdings across 54 positions as of 2026-Q3. Top-10 holdings account for 47.9% of reported value.

What is Sio Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sio-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →